유럽의 바이오 제조 바이러스 검출 및 정량화 시장 : 분석과 예측(2023-2032년)

Europe Biomanufacturing Viral Detection and Quantification Market - Analysis and Forecast, 2023-2032

US $ 1,225 ￦ 1,768,000

PDF and Excel (1-3 User License)

PDF 및 Excel 보고서를 동일 사업장에서 3명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 1,975 ￦ 2,851,000

PDF and Excel (Global License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

유럽의 바이오 제조 바이러스 검출 및 정량화 시장 규모는 2022년에 1억 3,730만 달러를 기록했습니다.

이 시장은 2032년에는 3억 4,590만 달러에 달할 것으로 예측되며, 예측 기간인 2023-2032년 CAGR은 9.80%에 달할 것으로 전망됩니다. 바이오의약품의 사용 확대와 바이러스 검사 기술의 향상이 유럽의 바이오 제조 바이러스 검출 및 정량화 시장의 성장을 촉진할 것으로 예측됩니다.

주요 시장 통계
예측 기간	2023-2032년
2023년 평가	1억 4,920만 달러
2032년 예측	3억 4,590만 달러
CAGR	9.8%

유럽의 바이오 제조 바이러스 검출 및 정량화 시장은 바이오 의약품의 사용 확대로 인해 빠르게 성장하고 있습니다. 바이오 의약품에 대한 수요가 증가함에 따라 이들 제품의 안전성, 유효성 및 일관성을 보장하는 것이 점점 더 중요해지고 있습니다. 규제를 준수하고 제품의 무결성을 유지하기 위해서는 강력한 품질 관리 절차가 필요합니다. 이러한 절차 중 하나는 바이오 제조 중 바이러스 오염을 측정하는 것입니다. 이에 따라 유럽의 바이오 제조 바이러스 검출 및 정량화 시장에서 소모품 및 장비에 대한 수요가 급증하고 있습니다. 기술적 개선과 높은 수준의 유지에 대한 노력으로 이 시장은 이 분야에서 지속적 인 성장을 이룰 수 있는 좋은 위치에 있습니다.

유럽의 바이오 제조 바이러스 검출 및 정량화 시장에 대해 조사했으며, 시장의 개요와 오퍼링 유형별, 기술별, 용도별, 최종사용자별, 국가별 동향 및 시장에 참여하는 기업의 개요 등을 제공하고 있습니다.

목차

제1장 제품의 정의

제2장 시장의 범위

제3장 조사 방법

제4장 유럽

• 개요
• 유럽
  • 유럽의 바이오 제조 바이러스 검출 및 정량화 시장(오퍼링 유형별)
  • 유럽의 바이오 제조 바이러스 검출 및 정량화 시장(기술별)
  • 유럽의 바이오 제조 바이러스 검출 및 정량화 시장(용도별)
  • 유럽의 바이오 제조 바이러스 검출 및 정량화 시장(최종사용자별)
  • 유럽의 바이오 제조 바이러스 검출 및 정량화 시장(국가별)

제5장 시장 - 경쟁 벤치마킹과 기업 개요

• 개요
• 기업 점유율 분석
• 바이오 제조 바이러스 검출 및 정량화 시장 참여 기업
• Merck KGaA
• Sartorius AG
• QIAGEN N.V

KSA

영문 목차

영문목차

“The Europe Biomanufacturing Viral Detection and Quantification Market Expected to Reach $345.9 Million by 2032.”

Introduction to Europe Biomanufacturing Viral Detection and Quantification Market

The Europe biomanufacturing viral detection and quantification market was valued at $137.3 million in 2022 and is anticipated to reach $345.9 million by 2032, witnessing a CAGR of 9.80% during the forecast period 2023-2032. The growing use of biopharmaceutical products and improvements in viral testing technologies are expected to drive the growth of the biomanufacturing viral detection and quantification market in the European market.

Market Introduction

KEY MARKET STATISTICS
Forecast Period	2023 - 2032
2023 Evaluation	$149.2 Million
2032 Forecast	$345.9 Million
CAGR	9.8%

The market for viral detection and quantification biomanufacturing in Europe is expanding quickly as a result of the growing use of biopharmaceutical products. Ensuring the safety, efficacy, and consistency of these products becomes increasingly important as the demand for biologics develops. Sturdy quality control procedures are necessary to comply with regulations and preserve product integrity. One such procedure is the measurement of viral contamination during biomanufacturing. As a result, the European biomanufacturing viral detection and quantification market is experiencing a surge in demand for consumables and instruments. With technological improvements and a commitment to upholding high standards, the market is well-positioned for ongoing growth in the area.

Market Segmentation:

Segmentation 1: by Offering Type

• Consumables
• Instruments
• Services

Segmentation 2: by Technology

• PCR
• ELISA
• Flow Cytometry
• Plaque Assay
• Others

Segmentation 3: by Application

• Blood and Blood Products Manufacturing
• Vaccines and Therapeutics Manufacturing
• Cellular and Gene Therapy Products Manufacturing
• Stem Cell Products Manufacturing
• Tissue and Tissue Products Manufacturing

Segmentation 4: by End User

• Life Science Companies
• Testing Laboratories
• CROs and CDMOs

Segmentation 6: by Country

• Germany
• France
• U.K.
• Spain
• Italy
• Rest-of-Europe

How can this report add value to an organization?

Workflow/Innovation Strategy: The biomanufacturing viral detection and quantification market (by offering type) has been segmented into consumables, instruments, and services. Moreover, the study provides the reader with a detailed understanding of the different applications of biomanufacturing viral detection and quantification in raw material preparation, upstream processing, downstream processing, and packaging.

Growth/Marketing Strategy: Biomanufacturing viral detection and quantification is being used for raw material preparation, upstream processing, downstream processing, and packaging. Various companies are providing products and services to aid in the viral testing of various biologic production, which is also the key strategy for market players to excel in the current biomanufacturing viral detection and quantification market.

Competitive Strategy: Key players in the Europe biomanufacturing viral detection and quantification market have been analyzed and profiled in the study, including manufacturers. Moreover, a detailed competitive benchmarking of the players operating in the Europe biomanufacturing viral detection and quantification market has been done to help the reader understand how players stack against each other, presenting a clear market landscape.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and regional presence.

Some of the prominent names in this market are:

Table of Contents

1 Product Definition

• 1.1 Inclusion and Exclusion Criteria

2 Market Scope

• 2.1 Key Questions Answered in the Report

3 Research Methodology

4 Europe

• 4.1 Overview
• 4.2 Europe
  • 4.2.1 Europe Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
  • 4.2.2 Europe Biomanufacturing Viral Detection and Quantification Market (by Technology)
  • 4.2.3 Europe Biomanufacturing Viral Detection and Quantification Market (by Application)
  • 4.2.4 Europe Biomanufacturing Viral Detection and Quantification Market (by End User)
  • 4.2.5 Europe Biomanufacturing Viral Detection and Quantification Market (by Country)
    • 4.2.5.1 Germany
      • 4.2.5.1.1 Germany Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 4.2.5.1.2 Germany Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 4.2.5.1.3 Germany Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 4.2.5.1.4 Germany Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 4.2.5.2 U.K.
      • 4.2.5.2.1 U.K. Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 4.2.5.2.2 U.K. Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 4.2.5.2.3 U.K. Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 4.2.5.2.4 U.K. Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 4.2.5.3 France
      • 4.2.5.3.1 France Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 4.2.5.3.2 France Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 4.2.5.3.3 France Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 4.2.5.3.4 France Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 4.2.5.4 Spain
      • 4.2.5.4.1 Spain Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 4.2.5.4.2 Spain Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 4.2.5.4.3 Spain Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 4.2.5.4.4 Spain Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 4.2.5.5 Italy
      • 4.2.5.5.1 Italy Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 4.2.5.5.2 Italy Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 4.2.5.5.3 Italy Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 4.2.5.5.4 Italy Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 4.2.5.6 Rest-of-Europe
      • 4.2.5.6.1 Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 4.2.5.6.2 Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 4.2.5.6.3 Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 4.2.5.6.4 Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by End User)

5 Markets - Competitive Benchmarking & Company Profiles

• 5.1 Overview
• 5.2 Company Share Analysis
• 5.3 Biomanufacturing Viral Detection and Quantification Ecosystem Active Players
• 5.4 Merck KGaA
  • 5.4.1 Company Overview
  • 5.4.2 Role of Merck KGaA in the Biomanufacturing Viral Detection and Quantification Market
  • 5.4.3 Key Competitors
  • 5.4.4 Financials
  • 5.4.5 Key Insights about the Financial Health of the Company
  • 5.4.6 Analyst Perspective
• 5.5 Sartorius AG
  • 5.5.1 Company Overview
  • 5.5.2 Role of Sartorius AG in the Biomanufacturing Viral Detection and Quantification Market
  • 5.5.3 Key Competitors
  • 5.5.4 Financials
  • 5.5.5 Analyst Perspective
• 5.6 QIAGEN N.V.
  • 5.6.1 Company Overview
  • 5.6.2 Role of QIAGEN N.V. in the Biomanufacturing Viral Detection and Quantification Market
  • 5.6.3 Key Competitors
  • 5.6.4 Financials
  • 5.6.5 Key Insights about the Financial Health of the Company
  • 5.6.6 Analyst Perspective

관련자료